✦ LIBER ✦

The need for pathological confirmation of the diagnosis of peritoneal malignant mesothelioma

✍ Scribed by Stanley J. Geyer

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 36 KB
Volume: 54
Category: Article
ISSN: 0271-3586
DOI: 10.1002/ajim.20959

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Analysis of hyaluronic acid in the diagn

Analysis of hyaluronic acid in the diagnosis of malignant mesothelioma

✍ Brian Chiu; Andrew Churg; Anders Tengblad; Richard Pearce; W. T. E. McCaughey 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB 👁 2 views

Observer variation in the pathologic dia

Observer variation in the pathologic diagnosis of malignant lymphoma in Canada

✍ Bruce Fraser Burns; W. T. Elliott McCaughey; Wendy Comrie; Andrew R. Willan 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB 👁 2 views

Cytologic diagnosis of malignant mesothe

Cytologic diagnosis of malignant mesothelioma, with particular emphasis on the epithelial noncohesive cell type

✍ Jennie Kho-Duffin; Liang-Che Tao; Harvey Cramer; Michele J. Catellier; Daniel Ir 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 376 KB 👁 1 views

The effusion cytologies from 21 cases of malignant mesothelioma (MM) (15 pleural, 6 peritoneal) diagnosed at the Indiana University Medical Center during 1990-1997 were reviewed. Using the classification of Tao (Acta Cytol 1979;23:209-213), 13 cases of MM were of the epithelial cohesive cell type an

Results of a phase II trial of combined

Results of a phase II trial of combined chemotherapy for patients with diffuse malignant mesothelioma of the pleura

✍ Sébastien Kasseyet; Philippe Astoul; Christian Boutin 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 283 KB 👁 2 views

## BACKGROUND. Malignant pleural mesothelioma is associated with a poor prognosis because of its resistance to treatment. The authors conducted a Phase II trial in which two drugs (etoposide and 5-fluorouracil) were added to the Cancer and Leukemia Group B cisplatin-mitomycin regimen in an effort t

Intrapleural administration of interleuk

Intrapleural administration of interleukin-2 for the treatment of patients with malignant pleural mesothelioma : A Phase II study

✍ Philippe Astoul; Diane Picat-Joossen; Jean-Regis Viallat; Christian Boutin 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

## Background: The prognosis associated with malignant pleural mesothelioma (mpm) is poor in spite of surgery, radiotherapy, photodynamic therapy, or chemotherapy. therefore, new therapeutic strategies, including intrapleural immunotherapy, are being investigated. several clinical studies have demo

Intrapleural administration of interleuk

Intrapleural administration of interleukin-2 for the treatment of patients with malignant pleural mesothelioma : A Phase II study

✍ Theodore G. Karrison; Nicholas J. Vogelzang 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB 👁 2 views

## Stage I Renal Cell Carcinoma I read the report by Kinouchi et al., 1 in which they concluded that the tumor grading of renal cell carcinoma was not predictive of the survival of Robson Stage I patients. This does not mean that the three-grading system is worthless; the authors simply showed tha